A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)
1 other identifier
interventional
29
1 country
1
Brief Summary
The purpose of this study is to evaluate the feasibility and outcomes of a research pre- and peri-transplant optimization program (R-PPOP) to improve multiple domains of health including physical function, cognitive function, mental health, and diet and nutrition for patients planning to undergo or undergoing hematopoietic stem cell transplantation (HCT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2019
CompletedFirst Posted
Study publicly available on registry
January 30, 2019
CompletedStudy Start
First participant enrolled
May 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 27, 2024
CompletedResults Posted
Study results publicly available
September 27, 2024
CompletedSeptember 27, 2024
September 1, 2024
3.5 years
January 28, 2019
October 10, 2023
September 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants Who Completed at Least Half of Their High Intensity Interval Training Sessions
Participants were asked to record or report their exercise sessions.
6 months
Other Outcomes (31)
Measuring Changes in the Skin Flora (Microbiome) in Caregivers
baseline, sign off, day 0 (transplant), 7, 14, 21, 30, 60, 90,180, 365
Changes in Fecal Samples as Measured by 16s rRNA Sequencing in Caregivers
baseline, sign off, day 0 (transplant), 7, 14, 21, 30, 60, 90,180, 365
Caregiver Quality of Life as Assessed by the Caregiver Strain Questionnaire
1 year
- +28 more other outcomes
Study Arms (2)
Patient
EXPERIMENTALThese are patients undergoing hematopoetic stem cell transplant. Patients will complete Interval training, undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.
Caregiver
EXPERIMENTALThese are the assigned caregivers for transplant patients. Caregivers will undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.
Interventions
Patients will be asked to complete up to 3 x 30-minute structured high intensity interval training aerobic exercise sessions/week. For the first session, patients will come to the Duke Center for Living for in person evaluation and training. After the initial training session in person, a subsequent training session will take place at the patient's home via iPad/iPhone videoconference using a device provided to the patient to provide additional support and the opportunity to answer questions. Subsequent sessions will be done independently by patients, but study staff will be available via iPad/iPhone if questions arise.
Subjects who score below threshold on the PHQ2/PHQ9, PC-PTSD/PCL-5, PROMIS-Depression and/or PROMIS-Anxiety assessments will be referred to a psychiatrist for follow up.
PG-SGA, ASA24, food group tracking Assessments and Vit D, Vit A, albumin, prealbumin, lipids, A1c levels will be used to provide weekly feedback for one month
Subjects who score below threshold on the PROMIS-Emotional Support and/or PROMIS-Social Isolation assessments will be referred to a social worker for follow up
Eligibility Criteria
You may qualify if:
- Plan to undergo an allogeneic hematopoietic stem cell transplant for any cancer or non-cancer illness within the next 6 months
- Age 18-80 years
You may not qualify if:
- Both patient and caregiver are unable to read and follow directions in English (ok if only patient cannot read and follow directions in English as caregiver will be able to help).
- Any absolute contraindications to exercise:
- recent (\< 6 months) acute cardiac event;
- unstable angina;
- uncontrolled dysrhythmias causing symptoms or hemodynamic compromise;
- symptomatic aortic stenosis;
- uncontrolled symptomatic heart failure;
- acute pulmonary embolus;
- acute myocarditis or pericarditis;
- suspected or known dissecting aneurism; or
- coronary artery disease.
- Functional impairment resulting in inability to exercise
- Identified by patient as their primary caregiver
- Age 18-80 years
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Adult Bone Marrow Transplant Clinic
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Anthony Sung
- Organization
- Duke University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Anthony Sung, MD
Duke Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2019
First Posted
January 30, 2019
Study Start
May 6, 2019
Primary Completion
October 27, 2022
Study Completion
April 27, 2024
Last Updated
September 27, 2024
Results First Posted
September 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share